Matthias G. Wacker

Associate Professor Matthias G. Wacker is a faculty member in the Department of Pharmacy and Pharmaceutical Sciences at the National University of Singapore (NUS). He earned his doctoral degree in pharmaceutical technology from Goethe University in Frankfurt (Germany), where he also completed his habilitation under the guidance of Jennifer Dressman and Jörg Kreuter at the Institute of Pharmaceutical Technology. Prior to joining NUS, he led the Department of Pharmaceutical Technology and Nanosciences at the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME).

​

He is an expert in the in vitro testing and characterization of dispersed dosage forms, with extensive involvement in several international committees, including the United States Pharmacopeial Convention‘s General Chapters – Dosage Forms Expert Committee and the Expert Panel on New Advancements in In-Vitro Product Performance Testing, as well as the International Organization for Standardization’s Technical Committee 229, which is responsible for developing nanotechnology standards. Additionally, he serves on the editorial boards of several prestigious journals (e.g., European Journal of Pharmaceutics and Biopharmaceutics, Frontiers in Chemistry, Journal of Pharmacy and Pharmacology).

​

His research emphasizes a quality-by-design approach for developing advanced dosage forms, focusing on biopredictive release and computational modeling to establish in vitro-in vivo correlations (IVIVC). Recognized for his contributions to pharmaceutical research, Prof. Wacker has received prestigious awards, including the Eudragit® Best Paper Award (2015) and the Phoenix Pharmaceutics Science Award (2017). Since 2022, he has been listed every year among the World’s Top 2% of Scientists by the Standford University Ranking. His work aims to enhance formulation design, ensuring a smooth transition from preclinical development to clinical application.